®™
Intervet will supply French government with a minimum quantity of 27 million doses of Bluetongue vaccine
Angers (INTERVET) – Today, Intervet received an official order of the Department for Agriculture and Fishery, France, to supply inactivated vaccine against Bluetongue, serotype 8.
Intervet is working intensively to supply the Bovilis BTV 8 vaccine to France as soon as possible, to support the French government and farming sector in its fight against this devastating disease.
As the global leader in the development and supply of vaccines to support animal health and welfare, Intervet has been actively working on this virus since its emergence in Northern Europe in 2006 and developed a vaccine against Bluetongue serotype 8 in a very short time to meet the urgent need as quickly as possible. Intervet already received firm orders from the UK and the Netherlands. Intervet is currently optimizing the production process and is doing the utmost to speed up the first deliveries for mid-spring.
The vaccine has been developed for sheep and for cattle. While sheep need to be vaccinated once, cattle will need two vaccinations. The Bluetongue control strategy and vaccine purchase and supply are defined by the national authorities.
Ropapharm international
Ropapharm germany